Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-21 dEsparbes Eric SVP and CFO Sale −1,825 $12.07 $22K 354,296
2017-02-20 Aguiar Michael W President & Chief Exec Officer Shares withheld for taxes −19,429 $12.04 $234K 1,059,281
2017-02-20 ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer Shares withheld for taxes −5,355 $12.04 $64K 269,838
2017-02-20 dEsparbes Eric SVP and CFO Shares withheld for taxes −8,604 $12.04 $104K 356,121
2017-02-20 Faerm Michael E. Sr VP & Chief Business Officer Shares withheld for taxes −5,860 $12.04 $71K 287,747
2017-02-20 Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. Shares withheld for taxes −6,367 $12.04 $77K 253,782
2017-01-17 Faerm Michael E. Sr VP & Chief Business Officer Grant or award +133,398 293,607
2017-01-17 Aguiar Michael W President & Chief Exec Officer Grant or award +333,495 1,078,710
2017-01-17 ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer Grant or award +106,718 275,193
2017-01-17 dEsparbes Eric SVP and CFO Grant or award +133,398 364,725
2017-01-17 WITEK THEODORE L JR Sr. VP & Chief Scientific Off. Grant or award +106,718 260,149
2016-11-21 dEsparbes Eric SVP and CFO Sale −1,800 $10.89 $20K 231,327
2016-11-20 dEsparbes Eric SVP and CFO Shares withheld for taxes −3,832 $10.91 $42K 233,127
2016-11-20 Faerm Michael E. Sr VP & Chief Business Officer Shares withheld for taxes −2,893 $10.91 $32K 160,209
2015-08-07 GLAXOSMITHKLINE PLC 10% owner Purchase +245,828 $3,485,841.04 $856.9B 32,005,260
2015-05-11 GLAXOSMITHKLINE PLC 10% owner Purchase +85,579 $1,369,264.00 $117.2B 31,759,432
2015-03-02 GLAXOSMITHKLINE PLC 10% owner Purchase +92,674 $1,673,692.44 $155.1B 31,673,853
2014-11-04 GLAXOSMITHKLINE PLC 10% owner Purchase +832,456 $12,786,524.16 $10644.2B 31,581,179
2014-08-11 GLAXOSMITHKLINE PLC 10% owner Purchase +172,651 $3,912,271.66 $675.5B 30,748,723
2014-05-09 GLAXOSMITHKLINE PLC 10% owner Purchase +317,770 $8,544,835.30 $2715.3B 30,576,072

Page 14 of 15 · 297 trades